27.01.2022 - The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health CanadaVANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) - KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) . Seite 1